Anja Ehrhardt
Impact in
- Genetics top 1%
- Virus-based gene therapy research
- Molecular Biology top 2%
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
Papers in
- Genetics 92
- Virus-based gene therapy research 89
-
- CRISPR and Genetic Engineering 11
- RNA Interference and Gene Delivery 6
- Co-authors
- Mark A. Kay (16 shared papers)Clare E. Thomas (1 shared paper)Wenli Zhang (52 shared papers)Christina Rauschhuber (10 shared papers)Martin Mück-Häusl (10 shared papers)Eric Ehrke‐Schulz (29 shared papers)Armin E. Baiker (11 shared papers)Nadine Müther (6 shared papers)
- Journals
- Viruses (13 papers)Molecular Therapy — Methods & Clinical Development (8 papers)Molecular Therapy (8 papers)Human Gene Therapy (7 papers)PLoS ONE (5 papers)
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Anja Ehrhardt
118 papers receiving 5.8k citations
Anja Ehrhardt's Hit Papers
Peers
Comparison fields: 5 of 119
- Genetics 2.5k
- Molecular Biology 2.4k
- Genetics 143
- Biomaterials 194
- Biotechnology 102
Countries citing papers authored by Anja Ehrhardt
This map shows the geographic impact of Anja Ehrhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Ehrhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Ehrhardt more than expected).
Fields of papers citing papers by Anja Ehrhardt
This network shows the impact of papers produced by Anja Ehrhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Ehrhardt. The network helps show where Anja Ehrhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Anja Ehrhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Progress and problems with the use of viral vectors for gene therapy Hit paper breakdown → | 2003 | 2131 |
| 2 | 2003 | 403 | |
| 3 | 2012 | 369 | |
| 4 | 2002 | 164 | |
| 5 | 2002 | 118 | |
| 6 | 2017 | 114 | |
| 7 | 2004 | 113 | |
| 8 | 2016 | 91 | |
| 9 | 2007 | 89 | |
| 10 | 2008 | 84 | |
| 11 | 2017 | 83 | |
| 12 | 2003 | 79 | |
| 13 | 2022 | 78 | |
| 14 | 2006 | 70 | |
| 15 | 2010 | 68 | |
| 16 | 2019 | 67 | |
| 17 | 2003 | 66 | |
| 18 | 2009 | 66 | |
| 19 | 2018 | 64 | |
| 20 | 2005 | 60 |
About Anja Ehrhardt
Anja Ehrhardt is a scholar working on Genetics, Molecular Biology, Physiology, Infectious Diseases and Hematology, having authored 122 papers that have together received 6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (89 papers), CRISPR and Genetic Engineering (11 papers), Asthma and respiratory diseases (8 papers), RNA Interference and Gene Delivery (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Hemophilia Treatment and Research (4 papers), Hepatitis B Virus Studies (3 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Genetics (2.5k citations), Molecular Biology (2.4k citations), Genetics (143 citations), Biomaterials (194 citations) and Biotechnology (102 citations). Anja Ehrhardt has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Mark A. Kay, Clare E. Thomas, Wenli Zhang, Christina Rauschhuber, Martin Mück-Häusl, Eric Ehrke‐Schulz, Armin E. Baiker, Nadine Müther, L. Jäger and Jian Jun Gao. Their work appears in journals such as Viruses, Molecular Therapy — Methods & Clinical Development, Molecular Therapy, Human Gene Therapy and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.